Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
08:26:45 EDT Sun 08 Sep 2024
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

T:MDNA - MEDICENNA THERAPEUTICS CORP. J - http://www.medicenna.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MDNA - T  5.02.20·2.472.02.21-0.21-8.7152.13364142.42  2.42  2.212.98  0.21515:59:59Sep 0515 min RT 2¢
TSX - T5.02.20·2.472.02.22-0.20-8.383.71862242.42  2.42  2.222.98  0.21515:59:5315 min
NEO ATS - U 2.26-0.16-6.61.63102.42  2.42  2.2615:56:4815 min
Alpha - A 2.25-0.17-7.021.348212.42  2.42  2.2315:57:3815 min
Omega - O 2.25-0.17-7.02.3542.26  2.26  2.2415:59:0115 min
Pure - P 2.24-0.18-7.40.4152.27  2.27  2.2415:50:4815 min
Chi-X - X 2.24-0.18-7.46.213362.41  2.42  2.2315:50:4815 min
CX2 - H 2.21-0.21-8.729.466542.39  2.42  2.2115:59:5915 min
CXD - D 2.23-0.19-7.91.94262.41  2.41  2.2315:48:4115 min
TriAct - M 2.425.31134    Sep 11-2015 min

Recent Trades - Last 10 of 414
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:59H2.21-0.216001 Anonymous79 CIBCK
15:59:53H2.22-0.201001 Anonymous1 AnonymousK
15:59:53T2.22-0.201001 Anonymous1 AnonymousK
15:59:52D2.24-0.184580 National Bank80 National BankE
15:59:50U2.24-0.183379 CIBC84 ITG84E
15:59:01O2.25-0.1710079 CIBC2 RBCK
15:57:38A2.25-0.1710079 CIBC79 CIBCK
15:56:48A2.23-0.1940039 Merrill Lynch1 AnonymousK
15:56:48T2.24-0.1810079 CIBC1 AnonymousK
15:56:48T2.24-0.181005 Citadel1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2024-08-27 07:00C:MDNA2.16News ReleaseMedicenna Announces Upcoming Presentations at The Promise of Interleukin-2 Therapy Conference
2024-08-15 15:46C:MDNA2.13News ReleaseMedicenna Therapeutics appoints Lalji to board
2024-08-01 07:00C:MDNA2.13News ReleaseMedicenna Reports First Quarter Fiscal 2025 Financial Results and Announces First Complete Responder with MDNA11 Monotherapy
2024-07-31 21:27C:MDNA2.13SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2024-07-31 21:27C:MDNA2.13SEDAR Interim MD & ASEDAR Interim MD & A
2024-07-26 16:52C:MDNA2.22MiscellaneousMedicenna Therapeutics has change in transfer agent
2024-06-27 18:36C:MDNA1.98News ReleaseMedicenna's March 31 cash position at $17-million
2024-06-27 00:52C:MDNA2.07SEDAR Annual Information FormSEDAR Annual Information Form
2024-06-27 00:39C:MDNA2.07SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2024-06-27 00:39C:MDNA2.07SEDAR MD & ASEDAR MD & A
2024-06-26 12:40C:MDNA2.07News ReleaseMedicenna receives EMA approval for Ability-1 trial
2024-06-03 12:30C:MDNA2.57News ReleaseMedicenna presents phase 2b bizaxofusp results at ASCO
2024-05-13 11:55C:MDNA2.47News ReleaseMedicenna denies breaking ASCO prior-publication policy
2024-04-30 14:50C:MDNA2.31News ReleaseMedicenna closes $20M investment from RA Capital
2024-04-26 09:09C:MDNA2.49News ReleaseMedicenna arranges $20M private placement
2024-04-26 08:09C:MDNA1.95Resume TradingMedicenna Therapeutics resuming at the open
2024-04-26 08:02C:MDNA1.95Halt TradingMedicenna Therapeutics halted at the open
2024-04-09 16:57C:MDNA1.50News ReleaseMedicenna presents MDNA11 clinical data at AACR
2024-04-09 15:21C:MDNA1.70News ReleaseMedicenna presents preclinical data on MDNA113 at AACR
2024-02-14 12:43C:MDNA0.86News ReleaseMedicenna Therapeutics' Dec. 31 cash at $21.8-million